Stock analysts at StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the stock.
Separately, HC Wainwright lifted their target price on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.
Get Our Latest Report on SenesTech
SenesTech Stock Performance
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- What is an Earnings Surprise?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What Are Treasury Bonds?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.